PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16498393-5	2006	We conclude that thymidine-containing PS-ODN can activate CLL cells and induce apoptosis via a mechanism that is independent of BCL-2 gene interference or CpG motifs.	Thymidine	17-26	BCL2 apoptosis regulator	Homo sapiens	128-133	
30717537-6	2018	In vitro, DT inhibited the proliferation of PC9 cell line in a concentration-dependent manner, and destroyed the structure of mitochondria in PC9 cell, promoted Bax, IRE1alpha, Bip, TRAF2 and caspase 12 protein expressions, lower Bcl-2 protein expression in a time-dependent manner.	Thymidine	10-12	BCL2 apoptosis regulator	Homo sapiens	230-235	
15647429-10	2005	Chondrocyte [(3)H]thymidine uptake correlated positively with Bcl-2 (r(s) = 0.62, p = 0.009) and correlated inversely with p53 levels (r(s) = -0.55, p = 0.02).	Thymidine	18-27	BCL2 apoptosis regulator	Homo sapiens	62-67	
9223329-9	1997	Fas-mediated apoptosis induced by the cytotoxic anti-Fas monoclonal antibody CH-11 was inhibited following adenoviral delivery of a Bcl-2 cDNA, and Bcl-2 also protected cells from acute apoptosis induced by dThd deprivation.	Thymidine	207-211	BCL2 apoptosis regulator	Homo sapiens	132-137	
9223329-9	1997	Fas-mediated apoptosis induced by the cytotoxic anti-Fas monoclonal antibody CH-11 was inhibited following adenoviral delivery of a Bcl-2 cDNA, and Bcl-2 also protected cells from acute apoptosis induced by dThd deprivation.	Thymidine	207-211	BCL2 apoptosis regulator	Homo sapiens	148-153	
18634067-10	1997	In conditions of excess thymidine, which suppressed cell proliferation, Ml cell density and specific mAb productivity were further enhanced by the overexpression of bcl-2, which suggests the possibility of accomplishing a controlled proliferation in immortalized cell lines without invoking cell death.	Thymidine	24-33	BCL2 apoptosis regulator	Homo sapiens	165-170	
8207068-6	1994	The expression and distribution of Bcl-2 is influenced by treatment with excessive thymidine.	Thymidine	83-92	BCL2 apoptosis regulator	Homo sapiens	35-40	
34790046-8	2021	Knockdown of CEBPA and BCL2 could alleviate the increasement of cisplatin resistance induced by CEBPA-DT overexpression.	Thymidine	102-104	BCL2 apoptosis regulator	Homo sapiens	23-27	
9474804-2	1997	The bcl-2/bag-1 transfectant survived maintaining viability above 75% for almost 5 days when the cells were treated with excess (30 mM) thymidine for arresting cell cycle, whereas the mock transfectant survived for only 2 days, and the bcl-2 alone transfectant lived for 4 days.	Thymidine	136-145	BCL2 apoptosis regulator	Homo sapiens	4-9	
9474804-3	1997	Owing to this extended viable culture period, the bcl-2/bag-1 transfectant produced twofold amount of antibody in comparison with the mock transfectant in non-proliferating state prepared by the excess thymidine treatment.	Thymidine	202-211	BCL2 apoptosis regulator	Homo sapiens	50-55	
18629863-9	1996	Results presented here suggest that suppression of apoptosis by bcl-2 under the condition of excess thymidine allows the maintenance of cells in a growth-arrested state for much longer than would otherwise be possible.When cells were transferred to a range of commercial serum-free media, cell growth was, in all cases, much better for the bcl-2 transfected cell line.	Thymidine	100-109	BCL2 apoptosis regulator	Homo sapiens	64-69	
8394449-4	1993	The expression of Bcl-2 in primary B cells infected with the B95-8 strain of EBV varied between 1 and 1.8 times that in uninfected cells when 50% of the cells were infected, expressed LMP, and incorporated 20-fold more [3H]thymidine than did uninfected cells.	Thymidine	223-232	BCL2 apoptosis regulator	Homo sapiens	18-23